TCM
TimesSquare Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,165
| Closed | -$638K | – | 242 |
|
|
2021
Q2 | $638K | Buy |
3,165
+200
| +7% | +$40.3K | 0.01% | 213 |
|
|
2021
Q1 | $637K | Buy |
2,965
+455
| +18% | +$97.8K | 0.01% | 212 |
|
|
2020
Q4 | $593K | Sell |
2,510
-425
| -14% | -$100K | ﹤0.01% | 219 |
|
|
2020
Q3 | $799K | Sell |
2,935
-13,550
| -82% | -$3.69M | 0.01% | 216 |
|
|
2020
Q2 | $4.79M | Sell |
16,485
-443,855
| -96% | -$129M | 0.05% | 205 |
|
|
2020
Q1 | $110M | Sell |
460,340
-21,530
| -4% | -$5.12M | 1.31% | 6 |
|
|
2019
Q4 | $106M | Sell |
481,870
-133,350
| -22% | -$29.2M | 0.94% | 17 |
|
|
2019
Q3 | $104M | Buy |
615,220
+105,030
| +21% | +$17.8M | 0.92% | 19 |
|
|
2019
Q2 | $93.6M | Sell |
510,190
-10,585
| -2% | -$1.94M | 0.72% | 37 |
|
|
2019
Q1 | $95.8M | Buy |
520,775
+49,855
| +11% | +$9.17M | 0.74% | 39 |
|
|
2018
Q4 | $78M | Sell |
470,920
-84,160
| -15% | -$13.9M | 0.67% | 44 |
|
|
2018
Q3 | $107M | Sell |
555,080
-128,730
| -19% | -$24.8M | 0.71% | 40 |
|
|
2018
Q2 | $116M | Buy |
683,810
+163,480
| +31% | +$27.8M | 0.78% | 29 |
|
|
2018
Q1 | $84.8M | Buy |
520,330
+3,315
| +0.6% | +$540K | 0.58% | 56 |
|
|
2017
Q4 | $77.5M | Buy |
517,015
+51,325
| +11% | +$7.69M | 0.51% | 70 |
|
|
2017
Q3 | $70.8M | Sell |
465,690
-24,655
| -5% | -$3.75M | 0.47% | 77 |
|
|
2017
Q2 | $63.2M | Sell |
490,345
-81,755
| -14% | -$10.5M | 0.41% | 98 |
|
|
2017
Q1 | $62.6M | Sell |
572,100
-156,600
| -21% | -$17.1M | 0.4% | 103 |
|
|
2016
Q4 | $53.7M | Sell |
728,700
-6,210
| -0.8% | -$457K | 0.36% | 109 |
|
|
2016
Q3 | $64.1M | Buy |
734,910
+25,000
| +4% | +$2.18M | 0.41% | 96 |
|
|
2016
Q2 | $61.1M | Buy |
+709,910
| New | +$61.1M | 0.4% | 99 |
|
|
2015
Q1 | – | Sell |
-900
| Closed | -$107K | – | 257 |
|
|
2014
Q4 | $107K | Hold |
900
| – | – | ﹤0.01% | 245 |
|
|
2014
Q3 | $101K | Buy |
900
+600
| +200% | +$67.3K | ﹤0.01% | 245 |
|
|
2014
Q2 | $28K | Buy |
+300
| New | +$28K | ﹤0.01% | 239 |
|